Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital

被引:35
作者
Goloubeva, V
Lecocq, M
Lassowsky, P
Matthys, F
Portaels, F
Bastian, I
机构
[1] Inst Med & Vet Sci, Adelaide, SA 5000, Australia
[2] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium
[3] Medecins Sans Frontieres, Brussels, Belgium
[4] Medecins Sans Frontieres, Mariinsk, Siberia, Russia
[5] Bacteriol Lab, Mariinsk, Siberia, Russia
关键词
D O I
10.1128/JCM.39.4.1501-1505.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The manual Mycobacteria Growth Indicator Tube (MGIT) method was evaluated for performing direct and indirect drug susceptibility testing (DST) of Mycobacterium tuberculosis for isoniazid and rifampin on 101 strongly smear-positive sputum specimens in a Siberian prison hospital, Using the indirect method of proportion (MOP) as the "gold standard," the accuracies of isoniazid and rifampin susceptibility testing by the direct MGIT system were 97.0 and 94.1%, respectively. The accuracy of the indirect MGIT system was 98.0% for both drugs. The turnaround times from specimen processing to reporting of the DST results ranged between 4 and 23 (mean, 9.2) days by the direct MGIT method, 9 and 30 (mean, 15.3) days by the indirect MGIT method, and 26 and 101 (mean, 59.6) days by the indirect MOP. MGIT appears to be a reliable, rapid, and convenient method for performing direct and indirect DSTs in low-resource settings, but further studies are required to refine the direct DST protocol. Cost is the only factor prohibiting widespread implementation of MGIT.
引用
收藏
页码:1501 / 1505
页数:5
相关论文
共 27 条
[1]  
Alcaide F, 2000, J CLIN MICROBIOL, V38, P398
[2]  
Bergmann JS, 2000, ARCH PATHOL LAB MED, V124, P82
[3]   Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin [J].
Bergmann, JS ;
Woods, GL .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 28 (03) :153-156
[4]  
CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
[5]   Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures [J].
Caviedes, L ;
Lee, TS ;
Gilman, RH ;
Sheen, P ;
Spellman, E ;
Lee, EH ;
Berg, DE ;
Montenegro-James, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (03) :1203-1208
[6]   Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay [J].
Franzblau, SG ;
Witzig, RS ;
McLaughlin, JC ;
Torres, P ;
Madico, G ;
Hernandez, A ;
Degnan, MT ;
Cook, MB ;
Quenzer, VK ;
Ferguson, RM ;
Gilman, RH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (02) :362-366
[7]   A multi-institutional outbreak of highly drug-resistant tuberculosis - Epidemiology and clinical outcomes [J].
Frieden, TR ;
Sherman, LF ;
Maw, KL ;
Fujiwara, PI ;
Crawford, JT ;
Nivin, B ;
Sharp, V ;
Hewlett, D ;
Brudney, K ;
Alland, D ;
Kreiswirth, BN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (15) :1229-1235
[8]   Two liquid medium systems, Mycobacteria Growth Indicator Tube and MB Redox tube, for Mycobacterium tuberculosis isolation from sputum specimens [J].
Heifets, L ;
Linder, T ;
Sanchez, T ;
Spencer, D ;
Brennan, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (03) :1227-1230
[9]  
HEIFETS L, 2000, MULTIDRUG RESISTANT, P133
[10]   CURRENT PRACTICES IN MYCOBACTERIOLOGY - RESULTS OF A SURVEY OF STATE PUBLIC-HEALTH LABORATORIES [J].
HUEBNER, RE ;
GOOD, RC ;
TOKARS, JI .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (04) :771-775